Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

August 2007

Volume 28, Number 8
Infect Control Hosp Epidemiol 2007;28:951–958
0899-823X/2007/2808-0010$15.00
DOI: 10.1086/519177
Original Article

Risk Factors for Burkholderia cepacia Complex Bacteremia Among Intensive Care Unit Patients Without Cystic Fibrosis: A Case‐Control Study

Adam M. Bressler, MD;

Keith S. Kaye, MD;

John J. LiPuma, MD;

Barbara D. Alexander, MD;

Christopher M. Moore, MD;

L. Barth Reller, MD;

Christopher W. Woods, MD

From the Infectious Disease Specialists of Atlanta and the Clinical Microbiology Laboratory, Dekalb Medical Center, Atlanta, Georgia (A.M.B.); the Department of Medicine (K.S.K., L.B.R., C.W.W.) and the Clinical Microbiology Laboratory (B.D.A., L.B.R., C.W.W.), Duke University School of Medicine, Durham, and the Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill (C.W.W.), North Carolina; the Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor (J.L.L.); and the University of Virginia School of Medicine, Charlottesville (C.M.M.).

Background.The Burkholderia cepacia complex is associated with colonization or disease in patients with cystic fibrosis (CF). For patients without CF, this complex is poorly understood apart from its presence in occasional point source outbreaks.

Objective.To investigate risk factors for B. cepacia bacteremia in hospitalized, intensive care unit patients without CF.

Methods.We identified patients with 1 or more blood cultures positive for B. cepacia between May 1, 1996, and March 31, 2002, excluding those with CF. Control patients were matched to case patients by ward, duration of hospitalization, and onset date of bacteremia. Matched analyses were used to identify risk factors for B. cepacia bacteremia.

Results.We enrolled 40 patients with B. cepacia bacteremia into the study. No environmental or other point source for B. cepacia complex was identified, although horizontal spread was suspected. Implementation of contact precautions was effective in decreasing the incidence of B. cepacia bacteremia. We selected 119 matched controls. Age, sex, and race were similar between cases and controls. In multivariable analysis, renal failure that required dialysis, recent abdominal surgery, 2 or more bronchoscopic procedures before detection of B. cepacia bacteremia, tracheostomy, and presence of a central line before detection of B. cepacia bacteremia were independently associated with development of B. cepacia bacteremia, whereas presence of a percutaneous feeding tube was associated with a lower risk of disease.

Conclusions.B. cepacia complex is an important emerging group of nosocomial pathogens in patients with and patients without CF. Nosocomial spread is likely facilitated by cross‐transmission, frequent pulmonary procedures, and central venous access. Infection control measures appear useful for limiting the spread of virulent, transmissible clones of B. cepacia complex.

Received November 26, 2006; accepted March 5, 2007; electronically published June 29, 2007.

Address reprint requests to Christopher W. Woods, Clinical Microbiology Laboratory, 113 Durham Veterans Affairs Medical Center, Durham, NC 27705 ().
  • Presented in part: 41st annual meeting of the Infectious Diseases Society of America; San Diego; October 2003 (abstract 577).

Close Popup